OPRK1 and acute kidney injury: This study evaluated the effects of difelikefalin, a kappa opioid receptor (KOR) agonist, on the inflammatory response and renal dysfunction in a rat model of acute kidney injury induced by renal ischemia–reperfusion injury, comparing it with other KOR agonists.